drugset / Trial / NCT06315634
Intrathecal Dexmedetomidine vs Midazolame
RandomizedParallel-groupTriple-blindTreatment
Summary
Prospective Randomized Controlled Clinical Trial to Compare Intrathecal Dexmedetomidine Versus Midazolame in Orthopedic Cancer Surgeries
Timeline
- Start
- 2021-03-15
- Primary completion
- 2022-03-10
- Completion
- 2022-03-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 5 ug | Intrathecal |
| Subject | Midazolam | Small molecule | 2 mg | Intrathecal |
| Background | Bupivacaine | Other / unclassified | 12.5 mg | Intrathecal |
Indications
No indication recorded.